Asthma: all 4,012 studies

Page 12 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and AdolescentsCompletedNCT01159912Phase 3Results posted
• Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in ObesityCompletedNCT01158573Results posted
• Efficacy, Safety and Pharmacokinetics of Different Regimens of IndacaterolCompletedNCT01156844Phase 2Results posted
• Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of AgeCompletedNCT01156792Phase 2Results posted
• Positive Airway Pressure for the Treatment of AsthmaCompletedNCT01154699Not applicableResults posted
• A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaCompletedNCT01152450Phase 2Results posted
• HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsCompletedNCT01147848Phase 3Results posted
• Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once DailyCompletedNCT01147744Phase 2Results posted
• Characterization of Placebo Responses in Stable AsthmaCompletedNCT01143688Not applicableResults posted
• Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy VolunteersCompletedNCT01143051Phase 1/2Results posted
• Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)CompletedNCT01142947Not applicableResults posted
• A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With PlaceboCompletedNCT01136382Phase 2Results posted
• Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsCompletedNCT01134042Phase 3Results posted
• Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic ResponseCompletedNCT01128595Phase 2Results posted
• Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic ResponseCompletedNCT01128569Phase 2Results posted
• Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate AsthmaCompletedNCT01122680Phase 2Results posted
• Study of Asthma and Nasal SteroidsCompletedNCT01118312Phase 4Results posted
• Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNCT01117116Not applicableResults posted
• A Pilot Study to Improve Preventive Asthma Care for Urban AdolescentsCompletedNCT01106326Not applicableResults posted
• A Multifaceted Prompting Intervention for Urban Children With AsthmaCompletedNCT01105754Not applicableResults posted
• BI 671800 in Asthmatic Patients on Inhaled CorticosteroidsCompletedNCT01103349Phase 2Results posted
• Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)CompletedNCT01097694Phase 2Results posted
• To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind StudyCompletedNCT01096017Phase 3Results posted
• BI 671800 ED in Steroid-naive Asthmatic PatientsCompletedNCT01092143Phase 2Results posted
• Bi 671800 in Asthmatic Patients on Inhaled CorticosteroidsCompletedNCT01090024Phase 2Results posted
• Asthma Exacerbation StudyCompletedNCT01086384Phase 3Results posted
• Role of Eosinophils in the Proliferation of Airway Smooth Muscle (ASM) CellsCompletedNCT01082952Results posted
• Efficacy and Safety of Different Doses of IndacaterolCompletedNCT01079130Phase 3Results posted
• Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaTerminatedNCT01070888Phase 4Results posted
• The Electronic Asthma Action Plan System for Implementation in Primary CareCompletedNCT01070095Not applicableResults posted
• Early Airway Response to Allergen in Asthmatics (MK-0000-176)CompletedNCT01061333Phase 1Results posted
• A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent AsthmaCompletedNCT01058863Phase 2Results posted
• The Study of Soy Isoflavones in AsthmaCompletedNCT01052116Phase 4Results posted
• Breath-Actuated Nebulizer Versus Conventional Continuous-Output Nebulizer in Pediatric Asthma PatientsTerminatedNCT01045174Not applicableResults posted
• Allergy Immunotherapy for the Reduction of AsthmaCompletedNCT01028560Phase 1/2Results posted
• Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty AcidsCompletedNCT01027143Phase 2/3Results posted
• Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety StudyCompletedNCT01018186Phase 3Results posted
• Moderate to Persistent Asthma in the Obese SubjectTerminatedNCT01016847Phase 4Results posted
• A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.CompletedNCT01013753Phase 2Results posted
• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon DevicesCompletedNCT01012739Phase 2Results posted
• Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled AsthmaCompletedNCT01007149Phase 3Results posted
• Dose Ranging Efficacy And Safety With Mepolizumab in Severe AsthmaCompletedNCT01000506Phase 2Results posted
• The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled AllergenCompletedNCT00999466Phase 2Results posted
• Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable AsthmaCompletedNCT00995904Phase 2Results posted
• A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory AsthmaCompletedNCT00994175Phase 2Results posted
• Efficacy and Safety Study in Subjects With AsthmaCompletedNCT00980200Phase 2Results posted
• A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate AsthmaTerminatedNCT00974675Phase 1Results posted
• A Study to Evaluate the Effectiveness and Safety of MEDI-528 in AdultsCompletedNCT00968669Phase 2Results posted
• Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )CompletedNCT00968201Phase 3Results posted
• Telecommunication Enhanced Asthma ManagementCompletedNCT00958932Not applicableResults posted
• Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)CompletedNCT00943683Not applicableResults posted
• Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)CompletedNCT00943397Phase 3Results posted
• Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With AsthmaCompletedNCT00941798Phase 2Results posted
• Dose-response of Albuterol in AsthmaticsCompletedNCT00940927Phase 4Results posted
• Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across AsiaCompletedNCT00939341Phase 4Results posted
• Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent AsthmaCompletedNCT00928668Phase 2Results posted
• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With AsthmaCompletedNCT00927901Phase 2Results posted
• Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)CompletedNCT00920621Phase 3Results posted
• Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)CompletedNCT00915538Phase 4Results posted
• The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)CompletedNCT00911547Phase 3Results posted
• Progression of Airway Obstruction in Childhood AsthmaCompletedNCT00873873Results posted
• Study to Evaluate the Safety and Efficacy of CAT-354CompletedNCT00873860Phase 2Results posted
• Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic AsthmaCompletedNCT00870584Phase 4Results posted
• Ramelteon for Insomnia Comorbid With AsthmaTerminatedNCT00869167Phase 3Results posted
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00862641Phase 4Results posted
• Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)CompletedNCT00861926Phase 3Results posted
• A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild AsthmaticsCompletedNCT00857857Phase 2Results posted
• Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic PatientsCompletedNCT00855959Phase 3Results posted
• Safety of VSL#3 in Adult AsthmaticsTerminatedNCT00852124Phase 1/2Results posted
• GSK2190915 Moderate to Severe Asthma StudyTerminatedNCT00850642Phase 2Results posted
• Efficacy and Safety Study of GSK679586 in Patients With Severe AsthmaCompletedNCT00843193Phase 2Results posted
• Study to Investigate the Efficacy of Symbicort® SMART.CompletedNCT00839800Phase 3Results posted
• Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese PatientsCompletedNCT00837967Phase 3Results posted
• Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool AsthmaticsCompletedNCT00836641Phase 4Results posted
• Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)CompletedNCT00832455Phase 4Results posted
• Screening Scottish Swimmers for Asthma and RhinitisCompletedNCT00831428Results posted
• Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)CompletedNCT00829985Phase 1/2Results posted
• Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic AsthmaCompletedNCT00829179Phase 3Results posted
• A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic PatientsTerminatedNCT00819637Phase 4Results posted
• 4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe AsthmaCompletedNCT00818454Phase 2Results posted
• Bosentan for Poorly Controlled AsthmaTerminatedNCT00815347Phase 2Results posted
• A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following ExerciseCompletedNCT00812929Phase 2Results posted
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With AsthmaCompletedNCT00809757Phase 3Results posted
• Treatment of Bronchial Asthma With Borage and Echium Seed OilsCompletedNCT00806442Phase 1/2Results posted
• Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)TerminatedNCT00787644Phase 2Results posted
• Fenzian Asthma Multicenter Outcomes StudyCompletedNCT00784758Not applicableResults posted
• The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic AsthmaticsCompletedNCT00784459Phase 2Results posted
• A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With AsthmaCompletedNCT00783289Phase 2Results posted
• Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)CompletedNCT00783198Phase 2/3Results posted
• Airway Smooth Muscle and Asthma SeverityCompletedNCT00779870Results posted
• The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)CompletedNCT00777764Phase 4Results posted
• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)CompletedNCT00776984Phase 3Results posted
• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)CompletedNCT00772538Phase 3Results posted
• A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).CompletedNCT00768079Phase 2Results posted
• Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of AsthmaCompletedNCT00766090Phase 2Results posted
• AZISAST Study: AZIthromycin in Severe ASThma StudyCompletedNCT00760838Phase 4Results posted
• One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled SteroidsCompletedNCT00758589Phase 2Results posted
• Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent AsthmaCompletedNCT00746330Phase 2Results posted
• The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)CompletedNCT00739297Phase 1Results posted
• PF-04191834 Single Dose Bronchodilatory Study In Asthma.CompletedNCT00723021Phase 2Results posted

← Asthma overview